Article Information
PubMed
Published By
History
- Received May 3, 2021
- Revision received August 9, 2021
- Accepted August 23, 2021
- Published online August 30, 2021.
Copyright & Usage
Copyright © 2021 Ztaou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Samira Ztaou1,2,
- Soo Jung Oh1,2,
- Sophia Tepler1,2,
- Sixtine Fleury1,2,
- Miriam Matamales3,
- Jesus Bertran-Gonzalez3,
- Nao Chuhma1,2 and
- Stephen Rayport1,2
- 1Department of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032
- 2Department of Psychiatry, Columbia University, New York, NY 10032
- 3Decision Neuroscience Laboratory, School of Psychology, University of New South Wales, Sydney, NSW 2052, Australia
- Correspondence should be addressed to Samira Ztaou at samira.ztaou{at}nyspi.columbia.edu or Stephen Rayport at stephen.rayport{at}nyspi.columbia.edu.
Author contributions
Author contributions: S.Z. and S.R. designed research; S.Z., S.J.O., S.T., and S.F. performed research; S.Z., M.M., and J.B.-G. analyzed data; S.Z., N.C., and S.R. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by National Institutes of Health Grants R01 DA038966 and R01 MH117128 (to S.R.), Philippe Foundation (to S.Z.), Australian Research Council Grants DP190102511 and DP210102700, and National Health and Medical Research Council Grants APP1165990 (to J.B.-G. and M.M.) and FT200100502 (to J.B.-G.).
Funding
HHS | NIH | National Institute on Drug Abuse (NIDA)
NIH R01 DA038966HHS | NIH | National Institute of Mental Health (NIMH)
NIH R01 MH117128Australian Research Council (ARC)
ARC DP190102511; ARC DP210102700; FT200100502Department of Health | National Health and Medical Research Council (NHMRC)
NHMRC APP1165990
Other Version
- You are viewing the most recent version of this article.
- previous version (August 30, 2021).
Article usage
In this issue
Single Dose of Amphetamine Induces Delayed Subregional Attenuation of Cholinergic Interneuron Activity in the Striatum
